Cited by 237Cardiovascular and exercise physiologyPhysical Activity and HealthCardiovascular Effects of Exercise

The DOI matches its Crossref record; 203 of the 205 references it cites were found in a registry or an index; 4 of the 149 sources its claims cite were checked for support.

Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation

Open access
Valenzuela, Pedro L, Ruilope, Luis M, Santos-Lozano, Alejandro, Wilhelm, Matthias, Kränkel, Nicolle, Fiuza-Luces, Carmen, Lucia, Alejandro·2023·European Heart Journal

Abstract

There is a pandemic of physical inactivity that appears to parallel the widespread prevalence of cardiovascular disease (CVD). Yet, regular physical activity (PA) and exercise can play an important role not only in primary cardiovascular prevention but also in secondary prevention. This review discusses some of the main cardiovascular effects of PA/exercise and the mechanisms involved, including a healthier metabolic milieu with attenuation of systemic chronic inflammation, as well as adaptations at the vascular (antiatherogenic effects) and heart tissue (myocardial regeneration and cardioprotection) levels. The current evidence for safe implementation of PA and exercise in patients with CVD is also summarized.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review summarizes epidemiological and mechanistic evidence that regular physical activity/exercise reduces cardiovascular disease risk and mortality in primary and secondary prevention, with dose-dependent benefits and multiple biological mechanisms. It also discusses controversies around high-volume endurance exercise, atrial fibrillation, coronary calcification, and the occupational physical activity paradox.

Key findings

  • In primary prevention, meeting WHO recommendations for moderate or vigorous physical activity was associated with 19%–25% and 15%–31% lower CVD and all-cause mortality risk, respectively, in a 30-year follow-up of 116,221 adults; the highest quarter of total moderate-to-vigorous physical activity had 53% lower incident CVD risk, and each 2,000 daily steps was associated with 10% lower CVD incidence up to ∼10,000 steps/day.
  • In secondary prevention, a 6-year follow-up of 131,558 CVD patients found 14% mortality risk reduction per 500 MET-min/week versus 7% in CVD-free referents; cardiac rehabilitation participation was associated with 32% lower mortality, and a Cochrane review of 23,430 CHD patients found exercise-based rehabilitation reduced mortality and improved quality of life.
  • Regarding “too much” exercise, a meta-analysis of 35,920 athletes found 27% lower standardized mortality rate, and MVPA at 5,000 MET-min/week was associated with 27% lower CVD mortality than 750 MET-min/week; however, sports participation was associated with 64% higher atrial fibrillation risk, while no robust evidence was found for total or intense physical activity.
  • Mechanistic evidence includes exercise-induced exerkines, vascular and endothelial improvements, myocardial regeneration, antiarrhythmogenic autonomic effects, and cardiac preconditioning; in obese mice, exercise training reduced myocardial infarction lesions by 67%, and each 1-MET increase in cardiorespiratory fitness was associated with 13% lower CVD mortality risk, with 51% lower risk at highest versus lowest fitness.

Methods

  • Design: narrative review of epidemiological, clinical, and preclinical evidence on physical activity/exercise in cardiovascular disease prevention and mechanisms.
  • Data or sample: no primary data were generated or analysed; the paper synthesizes cited cohort studies, meta-analyses, randomized controlled trials, and preclinical studies.
  • Main analysis: narrative synthesis of dose-response associations, clinical outcomes, and proposed biological mechanisms, without a described systematic search or formal meta-analysis.

Limitations

  • Stated: the paper reports that no data were generated or analysed for the manuscript; it notes controversy about high-volume endurance exercise and potential methodological limitations in atrial fibrillation/physical activity studies, mainly non-objective determination of atrial fibrillation or physical activity.
  • Evident from the text: as a narrative review, it does not describe a systematic search strategy, formal risk-of-bias assessment, or quantitative pooling; conclusions rely heavily on observational and preclinical evidence, so causality is not established.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehad170

Cites

203 of 203 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

103 Not checked yet · 5 Own interpretation · 2 Supported · 1 Partly supported · accuracy not yet measured

Verify all 145 references — free account

Show all 72 claims

  • It may state two separate claims as one. 36
  • The quote only partly states this claim. 1
  • Probably not a substantial claim. 2
39 of 39
  • The paper relies on this without support.

    Maintenance of endothelial barrier function counteracts lipid accumulation in the subendothelial vascular wall, the initial step of atherosclerotic plaque formation.

    “Maintenance of endothelial barrier function counteracts lipid accumulation in the subendothelial vascular wall, the initial step of atherosclerotic plaque formation.”
1 of 1

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 205 references

Cited by

Sorted by citations

Items 101–200 of 237

Metadata

Authors
Valenzuela, P. L., Ruilope, L. M., Santos-Lozano, A., Wilhelm, M., Kränkel, N., Fiuza-Luces, C., & Lucia, A.
Affiliations
  • Universidad de Alcalá (ES)
  • Research Institute Hospital 12 de Octubre (ES)
  • Physical Activity and Health Research Group (PaHerg), Research Institute of the Hospital 12 de Octubre (‘imas12’) , 7 Planta, Bloque D., Av. de Córdoba s/n, Madrid 28041 , Spain
  • University of Bern (CH)
  • Charité – Universitätsmedizin Berlin (DE)
  • CIBER of Frailty and Healthy Aging (CIBERFES) , Madrid 28007 , Spain
Corresponding author
Valenzuela, Pedro L
Venue
European Heart Journal
Published
2023-04-03
Volume
44
Issue
21
Pages
1874-1889
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W4362505991
Cited by
237
References
205
Citations by year
2026: 67 · 2025: 82 · 2024: 69 · 2023: 19
FWCI
13.88
Type
journal article
Language
en
Open access
Locations
  • European Heart Journal (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • BORIS (University Library Bern) (submittedVersion)
  • RUIdeRA - Institutional University Repository (University of Castilla-La Mancha) (submittedVersion)
Funders
  • postdoctoral
  • by Instituto de Salud Carlos III (CP18/00034, CD21/00138).)
  • Ministry of Economy and Competitiveness (PI18/00139, PI20/00605)
  • Wereld Kanker Onderzoek
  • World Cancer Research Fund International (IIG_FULL_2021_007)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Keywords
physical activity, cardiovascular disease, primary prevention, secondary prevention, physical inactivity, chronic inflammation, antiatherogenic effects, vascular adaptation, cardiac regeneration, cardioprotection
MeSH terms
Cardiovascular Diseases, Cardiovascular System, Heart, Humans, Inflammation, Risk Factors, Exercise

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review